{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:28:09Z","timestamp":1790008089482,"version":"4.0.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T00:00:00Z","timestamp":1530057600000},"content-version":"am","delay-in-days":361,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1436120"],"award-info":[{"award-number":["1436120"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NC-LSAMP Program","award":["0217571"],"award-info":[{"award-number":["0217571"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.bbagen.2017.03.013","type":"journal-article","created":{"date-parts":[[2017,3,19]],"date-time":"2017-03-19T06:17:23Z","timestamp":1489904243000},"page":"1759-1769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["DJ-1, a Parkinson's disease related protein, aggregates under denaturing conditions and co-aggregates with \u03b1-synuclein through hydrophobic interaction"],"prefix":"10.1016","volume":"1861","author":[{"given":"Min","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9538-7575","authenticated-orcid":false,"given":"Shivaliben","family":"H. Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0216-5111","authenticated-orcid":false,"given":"Shubo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2017.03.013_bb0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03159935","article-title":"Pathology of Parkinson's disease - changes other than the nigrostriatal pathway","volume":"14","author":"Jellinger","year":"1991","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0010","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/ane.12563","article-title":"The genetic background of Parkinson's disease: current progress and future prospects","volume":"134","author":"Kalinderi","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson's disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2017.03.013_bb0020","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s12035-012-8333-2","article-title":"Agrochemicals, alpha-synuclein, and Parkinson's disease","volume":"47","author":"Silva","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0025","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fnins.2016.00408","article-title":"Alpha-synuclein oligomers-neurotoxic molecules in Parkinson's disease and other Lewy body disorders","volume":"10","author":"Ingelsson","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0030","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.3390\/ijms11114257","article-title":"alpha-Synuclein and DJ-1 as potential biological fluid biomarkers for Parkinson's Disease","volume":"11","author":"Waragai","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2010.06.009","article-title":"Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease","volume":"480","author":"Shi","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0040","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","article-title":"DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease","volume":"133","author":"Hong","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.bbagen.2017.03.013_bb0045","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.parkreldis.2009.03.002","article-title":"A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human alpha-synuclein A30P+A53T transgenic mice","volume":"15","author":"Ono","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0050","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1248\/bpb.25.853","article-title":"DJ-1, a target protein for an endocrine disrupter, participates in the fertilization in mice","volume":"25","author":"Okada","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0055","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/bi991447r","article-title":"Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid","volume":"39","author":"Conway","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2017.03.013_bb0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/07391102.2003.10506918","article-title":"A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders","volume":"21","author":"Uversky","year":"2003","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0065","doi-asserted-by":"crossref","first-page":"26846","DOI":"10.1074\/jbc.M403129200","article-title":"The flavonoid baicalein inhibits fibrillation of a-synuclein and disaggregates existing fibrils","volume":"279","author":"Zhu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0070","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0014-5793(02)02638-8","article-title":"Methionine oxidation inhibits fibrillation of human a-synuclein in vitro","volume":"517","author":"Uversky","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11010-010-0563-x","article-title":"Metals, oxidative stress and neurodegenerative disorders","volume":"345","author":"Jomova","year":"2010","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0080","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-5793(01)02597-2","article-title":"Pesticides directly accelerate the rate of a-synuclein fibril formation. A possible factor in Parkinson's disease","volume":"500","author":"Uversky","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0085","first-page":"21","article-title":"An analysis of environmental factors modulating fibrillation of a small neuro-protein a-synuclein","volume":"3","author":"Munishkina","year":"2004","journal-title":"J. Undergrad. Chem. Res."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0090","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/bbrc.1997.6132","article-title":"DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras","volume":"231","author":"Nagakubo","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0095","doi-asserted-by":"crossref","first-page":"17838","DOI":"10.1074\/jbc.M115.666271","article-title":"Epidermal growth factor-dependent activation of the extracellular signal-regulated kinase pathway by DJ-1 protein through its direct binding to c-Raf protein","volume":"290","author":"Takahashi-Niki","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0100","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.bbrc.2003.11.056","article-title":"Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition","volume":"312","author":"Yokota","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0105","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/10715760100301381","article-title":"DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin","volume":"35","author":"Mitsumoto","year":"2001","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10715760100300831","article-title":"Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat","volume":"35","author":"Mitsumoto","year":"2001","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0115","doi-asserted-by":"crossref","first-page":"31372","DOI":"10.1074\/jbc.M304221200","article-title":"Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease","volume":"278","author":"Tao","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0120","doi-asserted-by":"crossref","first-page":"31380","DOI":"10.1074\/jbc.M305878200","article-title":"The crystal structure of DJ-1, a protein related to male fertility and Parkinson's disease","volume":"278","author":"Honbou","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0014-5793(03)00764-6","article-title":"Crystal structure of DJ-1\/RS and implication on familial Parkinson's disease","volume":"549","author":"Huai","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0130","doi-asserted-by":"crossref","first-page":"13680","DOI":"10.1074\/jbc.M609821200","article-title":"Structural determinants of the C-terminal helix-kink-helix motif essential for protein stability and survival promoting activity of DJ-1","volume":"282","author":"Gorner","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0135","doi-asserted-by":"crossref","first-page":"44552","DOI":"10.1074\/jbc.M304517200","article-title":"Crystal structures of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domain","volume":"278","author":"Lee","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0140","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1073\/pnas.0530312100","article-title":"The 1.6-angstrom crystal structure of the class of chaperones represented by Escherichia coli Hsp31 reveals a putative catalytic triad","volume":"100","author":"Quigley","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0145","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.nbd.2011.05.014","article-title":"DJ-1 associates with synaptic membranes","volume":"43","author":"Usami","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0150","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1093\/hmg\/ddg304","article-title":"The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes","volume":"12","author":"Macedo","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0155","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2017.03.013_bb0160","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/ejn.12872","article-title":"Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1","volume":"41","author":"van der Merwe","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/hmg\/ddi007","article-title":"Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress","volume":"14","author":"Moore","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0170","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ana.10675","article-title":"The role of pathogenic DJ-1 mutations in Parkinson's disease","volume":"54","author":"Abou-Sleiman","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0175","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ana.10663","article-title":"Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation","volume":"54","author":"Hague","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0180","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1212\/WNL.40.7.1148","article-title":"Lewy body variant - reply","volume":"40","author":"Hansen","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2017.03.013_bb0185","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.bbagen.2017.03.013_bb0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1385\/NMM:4:1-2:49","article-title":"Interactions of amyloidogenic proteins","volume":"4","author":"Giasson","year":"2003","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0195","doi-asserted-by":"crossref","first-page":"12245","DOI":"10.1073\/pnas.211412398","article-title":"beta-Amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease","volume":"98","author":"Masliah","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0200","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1060627","article-title":"Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease","volume":"293","author":"Shimura","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2017.03.013_bb0205","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1523\/JNEUROSCI.19-14-05782.1999","article-title":"alpha-Synuclein shares physical and functional homology with 14-3-3 proteins","volume":"19","author":"Ostrerova","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0210","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1093\/hmg\/ddu275","article-title":"The chaperone-like protein 14-3-3 eta interacts with human alpha-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing alpha-synuclein cellular toxicity","volume":"23","author":"Plotegher","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0215","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jnen\/61.3.245","article-title":"14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains","volume":"61","author":"Kawamoto","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.307","article-title":"DJ-1 interactions with alpha-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease","volume":"5","author":"Zondler","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001884","article-title":"DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70","volume":"3","author":"Batelli","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2017.03.013_bb0230","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jmb.2005.12.030","article-title":"The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein","volume":"356","author":"Zhou","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0235","doi-asserted-by":"crossref","first-page":"491","DOI":"10.14336\/AD.2015.1213","article-title":"Novel insights into acid-sensing ion channels: implications for degenerative diseases","volume":"7","author":"Zhou","year":"2016","journal-title":"Aging Dis."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0240","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40035-015-0031-3","article-title":"Acid-sensing ion channels: potential therapeutic targets for neurologic diseases","volume":"4","author":"Liu","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0245","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12975-013-0305-y","article-title":"Acid-sensing ion channels contribute to neurotoxicity","volume":"5","author":"Chu","year":"2014","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0250","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/jnnp.62.3.290","article-title":"Cerebrospinal fluid lactate and pyruvate concentrations in patients with Parkinson's disease and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)","volume":"62","author":"Yamamoto","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbagen.2017.03.013_bb0255","doi-asserted-by":"crossref","first-page":"44284","DOI":"10.1074\/jbc.M105343200","article-title":"Metal-triggered structural transformations, aggregation, and fibrillation of human a-synuclein. A possible molecular link between Parkinson's disease and heavy metal exposure","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0260","doi-asserted-by":"crossref","first-page":"40186","DOI":"10.1074\/jbc.M305326200","article-title":"The association of a-synuclein with membranes affects bilayer structure, stability, and fibril formation","volume":"278","author":"Zhu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0265","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0003-2697(89)90046-8","article-title":"Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1","volume":"177","author":"Naiki","year":"1989","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0270","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/pro.5560020312","article-title":"Thioflavine T interaction with synthetic Alzheimer's disease beta-amylid peptides: detection of amyloid aggregation in solution","volume":"2","author":"LeVine","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0275","doi-asserted-by":"crossref","first-page":"12711","DOI":"10.1021\/la3021436","article-title":"Aggregation pathways of the amyloid beta(1-42) peptide depend on its colloidal stability and ordered beta-sheet stacking","volume":"28","author":"Jiang","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.bbagen.2017.03.013_bb0280","doi-asserted-by":"crossref","first-page":"38006","DOI":"10.1074\/jbc.M112.400580","article-title":"Combined effects of agitation, macromolecular crowding, and interfaces on amyloidogenesis","volume":"287","author":"Lee","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0285","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ab.2010.02.001","article-title":"Strategies to increase the reproducibility of protein fibrillization in plate reader assays","volume":"400","author":"Giehm","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0290","doi-asserted-by":"crossref","first-page":"24452","DOI":"10.1074\/jbc.M400004200","article-title":"Annular oligomeric amyloid intermediates observed by in situ atomic force microscopy","volume":"279","author":"Zhu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0295","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0300","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1021\/bi001315u","article-title":"Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein","volume":"39","author":"Rochet","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2017.03.013_bb0305","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/418291a","article-title":"Neurodegenerative disease: amyloid pores from pathogenic mutations","volume":"418","author":"Lashuel","year":"2002","journal-title":"Nature (London, United Kingdom)"},{"key":"10.1016\/j.bbagen.2017.03.013_bb0310","doi-asserted-by":"crossref","first-page":"50914","DOI":"10.1074\/jbc.M207225200","article-title":"Surface-catalyzed amyloid fibril formation","volume":"277","author":"Zhu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0315","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0959-440X(99)00049-4","article-title":"Amyloid fibrillogenesis: themes and variations","volume":"10","author":"Rochet","year":"2000","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0320","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1073\/pnas.041617698","article-title":"An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated beta-sheet structure for amyloid","volume":"98","author":"Balbirnie","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0325","doi-asserted-by":"crossref","first-page":"43495","DOI":"10.1074\/jbc.C100551200","article-title":"Stabilization of partially folded conformation during a-synuclein oligomerization in both purified and cytosolic preparations","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0330","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1074\/jbc.M010907200","article-title":"Evidence for a partially folded intermediate in a-synuclein fibril formation","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0335","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbapap.2003.12.008","article-title":"Conformational constraints for amyloid fibrillation: the importance of being unfolded","volume":"1698","author":"Uversky","year":"2004","journal-title":"Biochim. Biophys. Acta Protein Proteomics"},{"key":"10.1016\/j.bbagen.2017.03.013_bb0340","doi-asserted-by":"crossref","first-page":"44284","DOI":"10.1074\/jbc.M105343200","article-title":"Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein - a possible molecular link between Parkinson's disease and heavy metal exposure","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0345","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cbpa.2008.02.019","article-title":"Metals in Alzheimer's and Parkinson's diseases","volume":"12","author":"Barnham","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0350","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresrev.2006.08.001","article-title":"Congo red and protein aggregation in neurodegenerative diseases","volume":"53","author":"Frid","year":"2007","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0355","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1432-1033.2001.01877.x","article-title":"Self-oligomerization and protein aggregation of alpha-synuclein in the presence of Coomassie Brilliant Blue","volume":"268","author":"Lee","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0360","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1021\/bm3016994","article-title":"Different fates of Alzheimer's disease amyloid-beta fibrils remodeled by biocompatible small molecules","volume":"14","author":"Irwin","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bbagen.2017.03.013_bb0365","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0167-4838(00)00106-0","article-title":"Eosin interaction of alpha-synuclein leading to protein self-oligomerization","volume":"1481","author":"Shin","year":"2000","journal-title":"Biochim. Biophys. Acta Protein Struct. Mol. Enzymol."},{"key":"10.1016\/j.bbagen.2017.03.013_bb0370","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1110\/ps.9.12.2489","article-title":"Structural changes in alpha-synuclein affect its chaperone-like activity in vitro","volume":"9","author":"Kim","year":"2000","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbagen.2017.03.013_bb9000","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/protein\/6.4.383","article-title":"Evaluation of secondary structure of proteins from UV circular dichroism using an unsupervised learning neural network","volume":"6","author":"Andrade","year":"1993","journal-title":"Prot. Eng."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441651730096X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441651730096X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T03:52:26Z","timestamp":1759636346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030441651730096X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":75,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S030441651730096X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2017.03.013","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DJ-1, a Parkinson's disease related protein, aggregates under denaturing conditions and co-aggregates with \u03b1-synuclein through hydrophobic interaction","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2017.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}